If you catch Tollovid daily on sale, it's $150 for 2

New Post Public Reply Private Reply Replies (1) Message Board
redspeed freegriff #29583
590
If you catch Tollovid daily on sale, it's $150 for 2 bottles

If you take one a day that's $1.25 a day. If you take two, $2.50

About the price of a Freshly Brewed Coffee - Venti size whatever that is and far less than a Pumpkin Spice Latte Venti

Is Starbucks a products for the masses? idk, never been there except at an airport to get an overpriced croissant.

Tollovid is less then a Big Mac but are those for the masses either?

Tollovid might be more a less prices you find at your local Cannabis. Last time I drove by there was masses waiting in line to buy something.

Point is, people make choices based on what is important to them. Sacrafices. Tradeoffs.

I do agree there are a lot of people that wish they even had a chance at a choice of a Big Mac or Starbucks, but there are masses that do as well.

If the government wants to step in and help, fantastic. If insurance companies what to help, fantastic. They might figure out at some point a bottle of Tollovid Max is far cheaper than a hospital stay, but we are a ways away from that sinking in.

My copay for an ER visit is $250. Probably on it's way up. More than a bottle of Tollovid Max onsale with the BOGO2H. No brainer for me because if I am out of work, I will lose way more than $250.

If one dug into SOC, they would know what is included. If Gerald wasn't hand holding JP and people that invested way over their heads on twitter, maybe someone would have thought to ask him or did a 2 second google search?

Even if Gerald spends all his waking hours telling shareholders every last detail so they won't be concerned or upset, it's just more ammo for JP and the bedwetting crew to use.

https://www.idsociety.org/practice-guideline/...anagement/

Click on the second blue bar. Second column to the right to see what you could get in the hospital besides a meal and clean sheets.

Does it matter that people were getting Remsdesivir, oxygen, etc? Where do you draw the line in trial? Even better yet, who is going to try something new, while they are dying and they have been lead to believe remsdesivir may save their life?

Reminds me of when Gerald said on Thursday, if Tollovir gets and EUA, who the hell can they find to take a placebo? I think it's going to get an EUA. It would be immoral to watch people die without trying.

"Hey, just checked on Billy. He's not going to make it. Oh well, wish we could have tried Tollovid, but it's not EUA."

Is Gerald going to review the phase 2/3 trial design with me? No.

Do I expect him to. No.

Do I trust they know what they are doing. Yes or I wouldn't be invested.

Wasn't the formulation change in middle of a trial? Did they stop for months and start another one or was it part of the same trial? I can look on the trial websites. I thought what happens within the trials in confidential?

Doesn't bother me at all. I look at it as a blessing. I'd have to go back and look to see if it was actually strength that they were getting wasn't strong enough, so they cranked it up. Wouldn't be too far different than someone was getting x pills and took y pills.

What I learned over the years if I told my business customers everything they think they wanted to know, they'd jump on the window with worry. Anyway, I bought at the high and low of the week. At one point, I confess...
I did open the window. As the car was getting pretty hot.

Not concerned at all or disappointed in the progress and transparency, but that is just me. Everyone's expectations and risk tolerance is different for sure.

I agree about your last part. Seems like there will always be manipulators. Uplisting isn't the cure either. But if Todos continues on focusing and executing, that can solve a lot of it.












Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 4

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 8

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 5

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 9

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin's Value May Skyrocket, Insights from a PayPal Leader

Updated Category News Views 194

Understanding Bitcoin's Growth Potential Bitcoin (CRYPTO: BTC) continues to capture attention as analysts highlight its potential for substantial appreciation. Former PayPal president David Marcus emphasizes that Bitcoin is "still severely undervalued" and posits that its value could rival that of gold, potentially reaching an equivalent of $1.3 million per coin. Insights...

Continue Reading
EQT Corporation Announces Remarkable Earnings for 2024

Updated Category News Views 361

Q4 2024 Results of EQT Corporation EQT Corporation (NYSE: EQT) has recently revealed its impressive financial and operational results for the fourth quarter and full year of 2024. The earnings report shows a vigorous pace of production and optimizations that led to significant cash flow generation. Key Highlights from Q4 Some of the notable achievements for the fourth...

Continue Reading
Nature's Miracle Holding Inc. Secures $2 Million Investment Boost

Updated Category News Views 154

Nature's Miracle Holding Inc. Announces $2 Million Investment Nature's Miracle Holding Inc. (OTCQB: NMHI) has successfully secured a significant investment of $2 million through the issuance of convertible preferred shares. This financial boost comes from a private investor based in Asia and marks a pivotal moment for the company as it continues to innovate in the...

Continue Reading
Sekisui Specialty Chemicals Implements Global Price Increase

Updated Category News Views 146

Sekisui Specialty Chemicals Implements Price Increase Sekisui Specialty Chemicals recently announced a significant adjustment to the pricing of its Selvol product line, including Selvol Polyvinyl Alcohol, Selvol Ultiloc, Selvol Ultalux, and Selvol Premiol products. These price adjustments will come into effect as contracts allow and are designed to adjust to market trends...

Continue Reading
How Market Influencers Are Shaping CRDO Options Strategies

Updated Category News Views 123

Recent Activity in CRDO Options Major financial players have recently shown significant interest in Credo Technology Group, operating under the stock ticker CRDO. Our examination of the options trading history reveals intriguing insights, particularly highlighting 29 unusual trades that stand out in the current market landscape. Understanding the Sentiment Behind Trades A...

Continue Reading